48-year old male dies days after receiving the AstraZeneca jab

Rock musician, 48, died on May 19 2021 days after receiving the AstraZeneca jab. 


An inquest held at Newcastle Coroner's Court heard how the 48-year-old fell ill with a migraine on May 13, before his condition severely deteriorated in the following days.

The individual had suffered from an "excruciating" headache and called for an ambulance on May 15th. The paramedic who arrived on scene gave evidence at the inquest and said that the patient was “alert and sat up”. His temperature and blood pressure where in the “normal range”. She then advised the patient to go to hospital for further checks, but he said he did not want to go for fear of catching COVID. 

A couple of days later, on May 17, another paramedic was called to the patient's home, where he appeared “confused and vacant”. He already had a small seizure and was immediately taken to a hospital. The neurosurgeon who operated on the patient, said when he arrived, both of his pupils were unresponsive to light. By this point the patient had bleeding on the brain, causing it to swell, and he was then operated on. The surgeon said that he was “fully aware” Zion’s blood clot “was the result of his recent vaccination”. 

The individual was declared dead on the morning of May 19.

REFERENCES

https://www.bbc.com/news/uk-england-cumbria-62590403

https://www.chroniclelive.co.uk/news/north-east-news/man-died-after-astrazeneca-vaccination-24783910

https://www.mirror.co.uk/news/uk-news/widow-gets-120000-pay-out-27288259

https://www.dailymail.co.uk/news/article-9728411/Rock-musician-48-died-brain-haemorrhage-two-weeks-AstraZeneca-vaccine.html

https://www.imdb.com/name/nm5259339/bio

Comments

Post a Comment

Popular posts from this blog

A New Onset of Ulcerative Colitis post-2nd-breakthrough-COVID-19

Image
A 21-year-old non-smoking Caucasian male with a history of acute pancreatitis but no other medical issues or family history had two doses of the BNT162b2 mRNA COVID-19 vaccine.  Four months after the second dose he had his first episode of COVID-19. Although not hypoxic, he felt pretty unwell for a week, with a severe cough, fever, generalized body ache, headache, and loss of taste. He received the third dose of the vaccine two months after recovering from COVID. Nine months after the third dose, he had the second episode of COVID-19, during which he was mildly unwell for three days, recovered, and did not require any anti-viral medication or antibiotics. One week post the second episode of COVID-19, he developed diarrhea and abdominal pain. It then progressed to bloody diarrhea. Ulcerative colitis was diagnosed based on his clinical symptoms, biopsy changes, and the exclusion of other causes.  There are ten published case reports about the newly diagnosed ulcerative colitis associate
Read more

COVID in May

Image
Concerns about a potential resurgence of COVID-19 are mounting as summer 2024 approaches.  This is driven by several indicators, including social media posts, healthcare data, and wastewater surveillance across different regions. Our study findings corroborate this trend.  While many forecasters anticipate a surge, others expect a gradual increase through the end of May, and then a decline again around early June. Reports from social media suggest emerging clusters of COVID-19 in Texas, several Canadian provinces, the UK, and on cruises in northern regions such as a Norwegian cruise to Alaska.  Data from Alberta's Respiratory virus dashboard   (total weekly laboratory-confirmed COVID-19 cases) and wastewater surveillance in Calgary indicate an uptick in COVID-19 cases starting April 2024. The most recent statistics from Alberta Health reveal a significant increase in hospitalizations due to COVID-19, with 114 individuals currently hospitalized—an increase of more than 20% over two
Read more

Chronic SARS-CoV-2 Shedding

Image
Chronic viral shedding, a condition where the virus continues to be released from an individual's body long after the initial infection, has been observed in many infectious diseases, including COVID-19.  In such cases, individuals may remain asymptomatic or experience only mild symptoms while the virus persists. It remains detectable in repeated tests over an extended period and can still infect others even in nasal swab is negative (which happens quite often ). This was evident in our study.    Recent research by Conway et al. (2024) highlights the possibility of chronic SARS-CoV-2 infection, extending over several months and potentially years. Other studies have documented prolonged asymptomatic infections and extended viral shedding in moderate to severe beyond hospital discharge. Analysis of sequencing data on UK samples taken between 2 November 2020 and 15 August 2022 lead to estimates that 0.1–0.5% of infections may become persistent with typically rebounding high viral load
Read more